CHMP clears way for EU approval of Novartis’ MS drugNovartis’ multiple sclerosis drug has been given the green light by the European Medicines Agency’s CHMP scientific committee, Share XCHMP clears way for EU approval of Novartis’ MS drughttps://pharmaphorum.com/news/chmp-clears-way-for-eu-approval-for-novartis-ms-drug/
FDA extends review of Novartis’ MS drug ofatumumabThe FDA has extended its review of Novartis’ potential multiple sclerosis drug ofatumumab, pushing back a decision on the repurposed Share XFDA extends review of Novartis’ MS drug ofatumumabhttps://pharmaphorum.com/news/fda-extends-review-of-novartis-ms-drug-ofatumumab/
